首页> 美国政府科技报告 >MUC4 Abrogation of Herceptin Responsiveness in Breast Cancer
【24h】

MUC4 Abrogation of Herceptin Responsiveness in Breast Cancer

机译:mUC4消除赫赛汀对乳腺癌的反应

获取原文

摘要

Muc4 is a heterodimeric glycoprotein complex consisting of a peripheral mucin subunit tightly but noncovalently linked to a transmembrane subunit. Muc4 is overexpressed on a number of human breast tumors. Overexpression of Muc4 has been shown to block cell-cell and cell-matrix interactions, protect tumor cells from immune surveillance and promote metastasis. In addition, Muc4 has been shown to act as a ligand for ErbB2/HER2, the target of the therapeutic antibody Herceptin. Using A375 melanoma and MCF7 breast adenocarcinoma cells stably transfected with tetracycline regulatable Muc4, we have investigated whether its overexpression can repress antibody binding to cell surface-expressed ErbB2.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号